Expert: Barry Runyon
Expert: Barry Runyon
The COVID-19 pandemic disrupted life science organizations’ operational models ranging from halting research and development activities, disrupting supply chains and dramatically shifting the sales environment to virtual spheres.
Beyond the pandemic, life science organizations face new regulatory challenges, ongoing pricing and access pressures, shifting economic conditions, and demands for new value propositions that improve patient outcomes. Life science organizations are embracing digitalization to accelerate medical innovation and achieve added value from technology.
CIOs can use this research to prioritize digital initiatives that improve operational efficiency, unlock value and deliver personalized experiences in 2022.
Complete the form to get your free copy.